An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma

*Division of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital – McGill University Health Centre, Montreal, Quebec, Canada

†Department of Surgery & Cancer, Imperial College London, UK

‡Nuffield Department of Surgery, University of Oxford, UK

§Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

∥Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Sweden

¶Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden

#Department of General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

**Department of Surgery, University of Amsterdam, Amsterdam, Netherlands

††Cancer center Amsterdam, Amsterdam, Netherlands

‡‡Department of Surgery, Trinity Centre for Health Sciences, Trinity College Dublin, and St. James’s Hospital, Dublin 8, Ireland

§§Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Trust, Birmingham, UK

∥∥Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

J.C.-L. and S.M. are co-first authors for this paper.

The authors report no conflicts of interest.

[email protected]

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.annalsofsurgery.com.

留言 (0)

沒有登入
gif